Thus, we investigated the protein expression levels of MLH1, MSH2, MSH6, PMS2, β-Tubulin III, P53, Ki67 and TOPIIα, and the gene mutation of KRAS and BRAF in 289 specimens of sporadic CRC patients, and their implications on survival were also investigated. Here, TOP2A is linked to colorectal carcinoma.